Description

BSE announces listing of new Commercial Paper worth Rs. 100 crore issued by Manappuram Finance Limited on private placement basis, with maturity of 364 days.

Summary

BSE has listed new Commercial Paper issued by Manappuram Finance Limited on private placement basis. The instrument comprises 2,000 units of Rs. 5,00,000/- each (total issue size Rs. 100 crore), listed on the BSE Debt segment with effect from December 5, 2025. The Commercial Paper carries ratings of CARE A1+ and CRISIL A1+, with Axis Bank Limited acting as the Issuing and Paying Agent.

Key Points

  • Issuer: Manappuram Finance Limited
  • Security Type: Commercial Paper issued on private placement basis
  • Face Value: Rs. 5,00,000/- per unit
  • Issue Price: Rs. 4,64,515.50 per unit
  • Total Quantity: 2,000 units (Total issue size: Rs. 100 crore)
  • Market Lot: 1 unit
  • Scrip Code: 730695
  • Scrip ID: MFL031225
  • Detail Name: MFL-3-12-26-CP
  • ISIN Number: INE522D14OZ0 (Further listing under same ISIN)
  • Credit Rating: CARE A1+, CRISIL A1+
  • Allotment Date: December 4, 2025
  • Redemption Date: December 3, 2026
  • Tenor: 364 days
  • Issuing and Paying Agent: Axis Bank Limited

Regulatory Changes

No regulatory changes announced in this circular.

Compliance Requirements

  • Trading members must trade the securities only in dematerialized form under the specified ISIN Number INE522D14OZ0
  • Trading shall take place in standard denomination of Rs. 5 lakhs and multiples thereof
  • The tick size for the securities is 1 paise
  • All trading must be conducted through the BSE Debt segment

Important Dates

  • Notice Date: December 5, 2025
  • Listing Date: December 5, 2025
  • Deemed Date of Allotment: December 4, 2025
  • Date of Redemption: December 3, 2026

Impact Assessment

This is a routine debt instrument listing with minimal market-wide impact. The listing provides Manappuram Finance Limited with short-term funding at competitive rates, as evidenced by the high credit ratings (A1+ from both CARE and CRISIL). The Commercial Paper is relevant primarily to institutional investors in the debt market seeking highly-rated short-term instruments. The standard denomination of Rs. 5 lakhs ensures that only institutional and high-net-worth participants can trade these securities. No impact on equity markets or retail investors is anticipated.

Impact Justification

Routine commercial paper listing with no market-wide impact; relevant only to debt market participants and the specific issuer